NEW YORK, March 31 (Reuters) – French drugmaker Genfit SA on Thursday said it would begin a midstage trial this year of its experimental drug elafibranor to treat primary biliary cholangitis, a…
The post Genfit plans to test its drug in second liver disease appeared first on NASDAQ.